BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, July 17, 2025
See today's BioWorld Asia
Home
» Other news to note for Jan. 12, 2021
To read the full story,
subscribe
or
sign in
.
Other news to note for Jan. 12, 2021
Jan. 12, 2021
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: 3D Medicines, Abbvie, Aerpio, Aim Immunotech, Akston, Alteogen, Ana, Argenx, Baxter Biopharma Solutions, Biohaven, Biontech, Bold, Cheplapharm Arzneimittel, Cohbar, Cristal, Curevac, Emergex Vaccines, Fujifilm, Geovax Labs, Humanigen, Iacta, Immunitybio, Intas, Intravacc, Iovaxis, Kleo, Legochem, Merck KGaA, Microsoft, Moderna, Nantkwest, Neurobo, Novavax, Peptidream, Pfizer, Pharmabcine, Pharmaleads, SK Chemicals, Sosei Group, Standigm, Takeda, Targovax, Y-Biologics, Zai Lab.
BioWorld Asia
Briefs
Other news to note